Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-11-046798)

Filing Details

Accession Number:: 0001181431-11-046798
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-24 16:09:41
Reporting Period:: 2011-08-23

Filing Date:: 2011-08-24
Accepted Time:: 2011-08-24 16:09:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891288	Questcor Pharmaceuticals Inc	QCOR	Pharmaceutical Preparations (2834)	330476164

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1502375	Kristine Engelke	1300 North Kellogg Drive Suite D Anaheim CA 92807	Corp. Controller & Pao	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-23	4,000	$10.55	4,050	No	4	M	Direct
Common Stock	Disposition	2011-08-23	4,000	$26.00	50	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2011-08-23	4,000	$0.00	4,000	$10.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,000		2020-08-15	No	4	M	Direct

Footnotes

Non-qualified stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on August 16, 2010.
Ms. Engelke was granted non-qualified stock options to purchase 16,000 shares of Questcor Pharmaceuticals, Inc. common stock.25% of such stock options vested on August 16, 2011 and the remaining shares shall vest thereafter over the next 36 month period.